About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

HISAMITSU PHARMACEUTICAL CO.,INC.(4530) Financial Results

4530
TSE Prime
HISAMITSU PHARMACEUTICAL CO.,INC.
4,100
JPY
-19
(-0.46%)
Dec 23, 3:30 pm JST
26.18
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
ー
ー
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb, 2021 114,510 10,671 11,829 9,250 113.2 83.50 Apr 8, 2021 J-GAAP
Feb, 2022 120,193 9,337 12,638 9,658 118.9 84 Apr 7, 2022 J-GAAP
Feb, 2023 128,330 11,599 16,051 11,742 148.0 84.50 Apr 13, 2023 J-GAAP
Feb, 2024 141,706 13,167 19,649 13,969 181.6 85 Apr 11, 2024 J-GAAP
Feb, 2025 Guidance 152,000 14,500 18,900 15,800 215.4 90 Apr 11, 2024 J-GAAP
YoY +7.3% +10.1% -3.8% +13.1% +18.6%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 161,852 32,532 33,494 21,357 249.3
Fiscal Year Feb, 2016 Feb, 2009 Feb, 2012 Feb, 2014 Feb, 2014
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep - Feb, 2021 61,642 3,631 5,802 4,656 57.3 42 Apr 7, 2022 J-GAAP
Sep - Feb, 2022 68,711 6,686 7,181 5,238 66.0 42.25 Apr 13, 2023 J-GAAP
Sep - Feb, 2023 74,729 4,771 8,009 5,552 72.2 42.50 Apr 11, 2024 J-GAAP
Sep - Feb, 2024 Guidance 76,544 5,494 8,112 6,702 91.4 45 Oct 10, 2024 J-GAAP
YoY +2.4% +15.2% +1.3% +20.7% +26.6%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Feb, 2022 9,337 6,139 19,199 -13,060 -15,189 86,247 28.48 J-GAAP
Feb, 2023 11,599 -11,141 12,727 -23,868 -14,687 65,424 20.84 J-GAAP
Feb, 2024 13,167 15,676 18,188 -2,512 -16,691 66,366 20.19 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Mar - Aug, 2022 59,619 4,913 8,870 6,504 81.6 55.3 Oct 12, 2022 J-GAAP
Mar - Aug, 2023 66,977 8,396 11,640 8,417 108.3 59.2 Oct 6, 2023 J-GAAP
Mar - Aug, 2024 75,456 9,006 10,788 9,098 122.7 57.1 Oct 10, 2024 J-GAAP
YoY +12.7% +7.3% -7.3% +8.1% +13.3%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Sep - Nov, 2022 32,262 3,593 4,133 3,018 37.9 11.1 Jan 12, 2023 J-GAAP
Dec - Feb, 2022 36,449 3,093 3,048 2,220 28.0 8.5 Apr 13, 2023 J-GAAP
Mar - May, 2023 32,096 4,361 5,713 4,049 52.1 13.6 Jul 13, 2023 J-GAAP
Jun - Aug, 2023 34,881 4,035 5,927 4,368 56.2 11.6 Oct 6, 2023 J-GAAP
Sep - Nov, 2023 35,850 3,874 5,021 3,693 47.8 10.8 Jan 11, 2024 J-GAAP
Dec - Feb, 2023 38,879 897 2,988 1,859 24.2 2.3 Apr 11, 2024 J-GAAP
Mar - May, 2024 35,810 4,149 5,562 4,788 63.9 11.6 Jul 11, 2024 J-GAAP
Jun - Aug, 2024 39,646 4,857 5,226 4,310 58.1 12.3 Oct 10, 2024 J-GAAP
YoY +13.7% +20.4% -11.8% -1.3% +3.4%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 42,748 10,313 10,489 9,054 106.8
Fiscal Year Aug, 2015 Nov, 2007 Nov, 2007 Nov, 2016 Nov, 2016
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Feb, 2022 3,171.83 83.5 302,858 252,914 236,192 0.01 Apr 7, 2022 J-GAAP
Feb, 2023 3,294.20 81.6 313,917 256,105 235,569 0.01 Apr 13, 2023 J-GAAP
Feb, 2024 3,492.62 80.5 328,779 264,541 242,578 0.00 Apr 11, 2024 J-GAAP
Mar - Aug, 2024 ー 78.0 350,477 273,201 248,509 0.00 Oct 10, 2024 J-GAAP